Insider Trading June 26, 2026 05:51 PM

American Healthcare REIT Executive Mark Foster Sells $121,450 Worth of Shares

EVP, General Counsel & Secretary's divestment occurs as the real estate investment trust navigates strong Q1 earnings and a major capital raise.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
AHR

Mark E. Foster, the Executive Vice President, General Counsel, and Secretary at American Healthcare REIT, Inc. (NASDAQ:AHR), executed a sale of 2,500 shares of the company's common stock on June 24, 2026. The transaction, valued at $121,450, was completed at a per-share price of $48.58. Following this divestment, Foster retains direct ownership of 52,995 shares. The sale takes place as AHR shares trade near their 52-week high of $54.67, with the stock currently priced at $50.91. While InvestingPro analysis suggests the stock may be overvalued relative to its Fair Value, the company maintains a

American Healthcare REIT Executive Mark Foster Sells $121,450 Worth of Shares
AHR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Foster's sale of 2,500 shares at $48.58 per share reduces his direct holding to 52,995 shares, occurring as AHR trades near its 52-week high.
  • The company reported strong Q1 2026 normalized funds from operations per share of $0.50, beating consensus estimates of $0.47.
  • American Healthcare REIT announced a $705.6 million stock offering of 14 million shares, with BofA Securities as the underwriter, expected to close soon.

Mark E. Foster, Executive Vice President, General Counsel, and Secretary at American Healthcare REIT, Inc. (NASDAQ:AHR), executed a sale of 2,500 shares of the company's common stock on June 24, 2026. The transaction, valued at $121,450, was completed at a per-share price of $48.58. Following this divestment, Foster retains direct ownership of 52,995 shares. The sale takes place as AHR shares trade near their 52-week high of $54.67, with the stock currently priced at $50.91. While InvestingPro analysis suggests the stock may be overvalued relative to its Fair Value, the company maintains a "GREAT" financial health score. InvestingPro offers 14 additional tips for AHR, plus a comprehensive Pro Research Report covering this and 1,400+ other US equities.

In other recent news, American Healthcare REIT, Inc. reported strong first-quarter 2026 results, with normalized funds from operations per share reaching $0.50. This exceeded both Citizens' estimate of $0.46 and consensus estimates of $0.47. The company also reported funds available for distribution per share of $0.43, surpassing Citizens' estimate of $0.39, thanks to improved net operating income margins. Additionally, American Healthcare REIT announced a significant $705.6 million stock offering, involving 14 million shares, with BofA Securities as the underwriter. The offering is anticipated to close soon, pending customary conditions. Citizens reiterated a Market Outperform rating with a $60.00 price target, highlighting the company's acquisition growth. KeyBanc also raised its price target for the company's shares to $58.00, maintaining an Overweight rating, and increased its 2026 and 2027 funds from operations estimates by 5% and 6%, respectively. American Healthcare REIT disclosed $1 billion in awarded deals expected to close, focusing on senior housing operating properties.

American Healthcare REIT IncFollowAnalyze AHRIncluded in our AI-picked strategiesReview strategies50.91▼-0.01(-0.02%)Closed51.000.00(0.00%)After Hours17:45:581D1W1M6M1Y5YMaxCreated with Highcharts 11.4.814:0015:0016:0017:0018:0019:005051Analyze AHRThis article was generated with the support of AI and reviewed by an editor. For more information see our T&C.See the trade on AHR, but can't pull the trigger?Most traders can read a chart. The hard part is the moment: entry window open, pattern forming, and you're still waiting for more confirmation. That's the conviction gap and our chart analysis closes it. Unlike other AIs that just read data, our Vision AI literally "sees" your charts and hands you a complete trading plan: entry, stop-loss, and profit target in under 60 seconds. Know exactly what to do next, every time.Try Chart Analysis for AHR

Risks

  • InvestingPro analysis suggests the stock may be overvalued relative to its Fair Value, indicating potential valuation risks in the real estate sector.
  • The company's $705.6 million stock offering could dilute existing shareholders, impacting the real estate investment trust market.
  • Pending customary conditions for the stock offering closure introduce uncertainty regarding the timing and execution of the capital raise.

More from Insider Trading

Oak Valley Bancorp Director Don Barton Executes Share Sale Under Pre-Arranged Plan Jun 26, 2026 StubHub President Nayaab Islam Sells $302,141 in Company Shares Jun 26, 2026 Ionis Pharmaceuticals CEO Executes $6.8 Million Share Sale Under Pre-Arranged Plan Jun 26, 2026 Ionis Pharmaceuticals EVP Eric Swayze Offloads $839K in Shares Amid Regulatory Milestones Jun 26, 2026 Omada Health CFO Steven Cook Offloads $55,145 in Shares Under Pre-Arranged Plan Jun 26, 2026